Published on
August 25, 2026
- 14:15 GMT
PathNet Expands Urologic Pathology Offerings with PTEN and FGFR3 Biomarkers for Prostate and Bladder Cancer
PathNet announces it will bring PTEN and FGFR3 biomarker staining in-house. LITTLE ROCK, AR, UNITED STATES, August 25, 2026 /EINPresswire.com/ -- PathNet, one of the nation’s foremost pathology laboratories and largest independent urologic oncology …
Distribution channels:
Companies, Healthcare & Pharmaceuticals Industry
...
